Makerere University: Clinical Trials

322 trials sponsored by Makerere University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

180 completed, 86 unknown, 21 recruiting, 12 active not recruiting. 164 Not applicable, 48 Phase 3, 36 Phase 2, 26 Phase 4, 7 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable164Completed 91, Unknown 42, Recruiting 10, Not yet recruiting 9, Active not recruiting 8, Terminated 3, Enrolling by invitation 1
Phase 348Completed 28, Unknown 15, Recruiting 3, Not yet recruiting 1, Terminated 1
Phase 236Completed 14, Unknown 13, Recruiting 4, Not yet recruiting 2, Terminated 2, Enrolling by invitation 1
Phase 426Completed 19, Unknown 7
Phase 17Completed 3, Not yet recruiting 2, Recruiting 1, Terminated 1

Follow Makerere University: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Game Changers for Family Planning Peer Advocacy Program
Game Changers for Family Planning - Family Planning
Phase 1 / Phase 2Not yet recruitingRAND1922027-11-152025-12-31
Pilot of an Intervention to Reduce Alcohol Use and Improve ART Adherence Among Men Living With HIV With Pregnant Partners in Uganda.
Kisoboka Amaka, Screening and Referral - HIV Antiretroviral Therapy (ART) Adherence, Alcohol Consumption
Not applicableNot yet recruitingSan Diego State University602027-02-012026-06-22
An Adaptive Platform Trial for Evaluation of Novel Treatment Regimens in Children and Adolescents With HIV in Africa
Dolutegravir (DTG), Abacavir (ABC), Lamivudine (3TC) - HIV Infection
Phase 3Not yet recruitingUniversity College, London8002026-11-012026-08-28
I-CAN Uganda Effectiveness Trial
I-CAN - Contraception
Not applicableNot yet recruitingUniversity of California, San Francisco15602026-10-132026-07-23
Integrating Tuberculosis Treatment Into Community Pharmacies to Improve TB/HIV Outcomes in Uganda
The intervention is TB treatment delivery via community pharmacies for people with TB/HIV, Control Arm - standard of care - TB - Tuberculosis, HIV - Human Immunodeficiency Virus
Not applicableNot yet recruitingMakerere University1242026-10-012026-09-25
KeyScope Study in Uganda
KeySuite - Abdominal Neoplasm
Not applicableNot yet recruitingDuke University122026-09-012026-08-06
Relaxation Intervention to Improve Newborn Growth and Maternal Well-being
Relaxation audiorecording, Control audio device without relaxation audiorecording - Well-Being, Psychological, Breastfeeding
Not applicableRecruitingUniversity of California, San Francisco1002026-08-202026-10-13
Call for Life Sepsis
Interactive Voice Response system-Call for life IVR - Sepsis
Not applicableRecruitingMakerere University14102026-06-102026-08-12
TB SCReening Improves Preventive Therapy Uptake in Pregnant Women With HIV
CRP screening (TB screening intervention arm), Deferred TPT (TPT delivery trial intervention arm) - Pregnant HIV Positive Women, HIV
Not applicableNot yet recruitingUniversity of California, San Francisco15002026-06-012025-12-12
Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study
hydroxycarbamide - Sickle Cell Disease, Sickle Cell Anemia in Children
Phase 1 / Phase 2RecruitingChildren's Hospital Medical Center, Cincinnati2502026-05-132026-07-16
Precision Imaging to Evaluate Kaposi Sarcoma
SkinScan3D - Kaposi Sarcoma
Not applicableRecruitingWashington University School of Medicine1802026-04-102026-09-21
Evaluation of an Information Management and Communication System for Population-wide Point-of-Care Infant Sickle Cell Disease Screening
Sickle Cell Disease screening information management and communication system - Sickle Cell Disease
Not applicableRecruitingMakerere University240002026-03-252026-05-27
Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
Peer-Navigaton TB-EC Strategy, Usual TB-EC Strategy - Tuberculosis, HIV
Not applicableRecruitingYale University19202026-03-162026-03-20
In This toGether R01
Level up quizzes, Badges, On-demand advice - HIV
Not applicableNot yet recruitingCenter for Innovative Public Health Research7502026-03-012026-02-03
IBIS Megastudy of Interventions to Encourage HIV Retesting
Risk assessment messaging, U=U messaging, Community benefits messaging - HIV
Not applicableRecruitingUniversity of California, San Francisco400002025-12-092026-01-26
This Trial Aims to Evaluate the Effect of Two HIV Stigma Reduction Interventions at the Health Facility Level and the Individual Level for People Struggling to Access and Remain in Care in Uganda.
Health Policy Plus (HP+) Total Facility Approach (TFA) to Stigma Reduction, a clinic-level intervention and HIV Education, Empathy and Empowerment (HIVE3), an individual-level intervention. - HIV, Stigma
Not applicableActive not recruitingMakerere University1202025-11-272026-07-16
Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda
HIV Risk Reduction (HIVRR), PrEP Peer Supporters (PS), Matched Savings Accounts + Financial Literacy (FL) - HIV Prevention
Not applicableActive not recruitingWashington University School of Medicine6002025-10-202026-10-28
Economic Empowerment and Health Promotion of Uganda Grandmother-caregivers.
The BAJJAJJA intervention - Financial Burden, Health Behavior
Not applicableNot yet recruitingUniversity of Utah242025-10-012025-08-14
PDMC Implementation Trial in Kenya
SMS reminders; adherence support strategy a, Community Health Promoters (CHP) home visits; adherence support strategy b, No reminders; adherence support strategy c - Severe Malaria, Severe Anemia
Not applicableCompletedLiverpool School of Tropical Medicine6002025-09-052026-10-30
Reducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk Environments
Kisoboka, Behavioral Economics, Motivational Interviewing - HIV Antiretroviral Therapy (ART) Adherence, Alcohol Abuse
Not applicableRecruitingSan Diego State University7162025-06-162026-05-12

Showing 20 of 322. Sign in to see all of them.

Conditions studied

Acquired Immunodeficiency Syndrome (34)  ·  Malaria (32)  ·  Tuberculosis (31)  ·  HIV Infections (24)  ·  Pneumonia (11)  ·  Anemia, Sickle Cell (10)  ·  Noncommunicable Diseases (8)  ·  Malnutrition (7)  ·  Anemia (6)  ·  Breast Feeding (6)  ·  COVID-19 (6)  ·  Depression (6)  ·  Diarrhea (6)  ·  Hypertension (6)  ·  Alcohol Drinking (5)

Interventions

Artemether, Lumefantrine Drug Combination (11)  ·  Standard of Care (11)  ·  Lamivudine (6)  ·  efavirenz (6)  ·  dolutegravir (5)  ·  Hydroxyurea (4)  ·  Mass Screening (4)  ·  Nevirapine (4)  ·  Referral and Consultation (4)  ·  CD56 Antigen (3)  ·  Darunavir (3)  ·  Isoniazid (3)  ·  Methods (3)  ·  Misoprostol (3)  ·  Rifampin (3)

Countries

Uganda (280)  ·  Kenya (22)  ·  United States (11)  ·  South Africa (10)  ·  Bangladesh (7)  ·  Malawi (6)  ·  Mozambique (5)  ·  Nigeria (5)  ·  Ethiopia (4)  ·  Côte d’Ivoire (3)  ·  Nepal (3)  ·  Netherlands (3)  ·  Norway (3)  ·  Zambia (3)  ·  Burkina Faso (2)

Top investigators

Diane Havlir, MD (7)  ·  Gabriel Chamie, MD, MPH (6)  ·  Adnan A Hyder, PhD, MBBS (5)  ·  George W. Pariyo, PhD (4)  ·  Moses Kamya, MBChB, PhD (4)  ·  Renee Heffron, PhD, MPH (4)  ·  Thorkild Tylleskar, MD, PhD (4)  ·  Adithya Cattamanchi, MD (3)  ·  Glenn Wagner, PhD (3)  ·  James K Tumwine, PhD (3)  ·  Maya Petersen, PhD (3)  ·  Valerie Flaherman, MD, MPH (3)  ·  Victoria Nankabirwa, MD, MPH, PhD (3)  ·  Andrew Mujugira, PhD (2)  ·  Barnabas K Natamba, MPH, PhD (2)

Results publications

PMID 41762058, PMID 25022596, PMID 25297720, PMID 26632823, PMID 28052888, PMID 30325463, PMID 30340648, PMID 32604132, PMID 32843994, PMID 33110445, PMID 33945526, PMID 39630076, PMID 39972326, PMID 10190913, PMID 10216893, PMID 10501745, PMID 11807470, PMID 12160502, PMID 12663340, PMID 15069048, PMID 15485730, PMID 16878530, PMID 17958887, PMID 18555821, PMID 19096711, PMID 19295939, PMID 19362361, PMID 1949887, PMID 19622553, PMID 19852829, PMID 19877969, PMID 19948038, PMID 20525230, PMID 20569064, PMID 20573250, PMID 20634208, PMID 20683193, PMID 20716352, PMID 20858275, PMID 20889882, PMID 21047828, PMID 21126328, PMID 21372798, PMID 21383095, PMID 21454456, PMID 21513547, PMID 21573019, PMID 21600005, PMID 21745716, PMID 21752262

NIH funding

U01AI150510 (3), R01AA030464 (2), R01MH132438 (2), 2019 (1), D43TW011304 (1), K01AA031208 (1), K01MH083536 (1), K01MH121663 (1), K01TW012427 (1), K43TW012839 (1), R00HD086232 (1), R01AA031650 (1), R01AI051219 (1), R01AI125000 (1), R01AI190419 (1)